During the past decade, Immunitor LLC conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Immunitor LLC" #1 collaborator was "Ekomed LLC" with 1 trials as a collaborator, "Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare" with 1 trials as a collaborator and "Immunitor Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Immunitor LLC" are "HCC" (2 trials), "Atherosclerosis" (1 trials), "Breast Cancer" (1 trials), "Cervical Cancer" (1 trials) and "Cholangiocarcinoma" (1 trials). Many other conditions were trialed in "Immunitor LLC" in a lesser frequency.

Most popular intervention types in "Immunitor LLC" are "Biological" (12 trials). Other intervention types were less common.

The name of intervention was led by "Daily oral dose of hepcortespenlisimut-L" (1 trials), "Oral therapeutic vaccine V3-X to treat cholangiocarcinoma" (1 trials), "Placebo" (1 trials), "Placebo pills" (1 trials) and "Tableted vaccine (V3-OVA) containing ovarian cancer antigens" (1 trials). Other intervention names were less common.

The vast majority of trials in "Immunitor LLC" are 7 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Immunitor LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Immunitor LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Immunitor LLC, 2 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".